Erectile dysfunction (ED) is inconvenient enough on its own. The last thing you want is a pile-on of other inconveniences, like having to go to a doctor’s office for a diagnosis and prescription — and ...

Hims & Hers faces a pivotal regulatory moment as the FDA reconsiders compounded peptide therapies, especially GLP-1 drugs like semaglutide. A permissive FDA framework could legitimize compounded ...